From: The American Heart Association and MedPage Today [mailto:[log in to unmask]] Sent: Wednesday, October 24, 2012 12:31 To: [log in to unmask] Subject: New Stent Shows Promise for Acute STEMI Image removed by sender. <http://ad.doubleclick.net/jump/medpagetoday/emails/cardiodaily/aha;prof=;sp ec=cardiology;pos=top;ugc=0;ct=nl;dcove=r;tile=16;sz=728x90;u=5089051;ord=10 244C6C3F84901E6E1E17C5FE4A8DBCCCD3?> Image removed by sender. Image removed by sender. Cardiovascular Daily October 24, 2012 <http://broadcaster.medpagetoday.com/bin/ftaf?id=4C6C3F84901E6E1E17C5FE4A8DB CCCD3> Image removed by sender. FTAFForward to a Colleague! <http://broadcaster.medpagetoday.com/bin/ftaf?id=4C6C3F84901E6E1E17C5FE4A8DB CCCD3> Image removed by sender. ScienceNews Image removed by sender. Todays Headlines <http://broadcaster.medpagetoday.com/t?r=2&c=18331&l=368&ctl=6C904:4C6C3F849 01E6E1E17C5FE4A8DBCCCD3&&eun=gd3r&userid=89769&[log in to unmask]&mu _id=5089051> New Stent Shows Promise for Acute STEMI <http://broadcaster.medpagetoday.com/t?r=2&c=18331&l=368&ctl=6C904:4C6C3F849 01E6E1E17C5FE4A8DBCCCD3&&eun=gd3r&userid=89769&[log in to unmask]&mu _id=5089051> For patients with acute MI, emergency intervention with an investigational stent designed to prevent distal embolization resulted in higher rates of complete ST-segment resolution, a randomized trial showed. <http://broadcaster.medpagetoday.com/t?r=2&c=18331&l=368&ctl=6C904:4C6C3F849 01E6E1E17C5FE4A8DBCCCD3&&eun=gd3r&userid=89769&[log in to unmask]&mu _id=5089051> Full story <http://broadcaster.medpagetoday.com/t?r=2&c=18331&l=368&ctl=6C905:4C6C3F849 01E6E1E17C5FE4A8DBCCCD3&&eun=gd3r&userid=89769&[log in to unmask]&mu _id=5089051> CV Risk Factors Add Up to PAD <http://broadcaster.medpagetoday.com/t?r=2&c=18331&l=368&ctl=6C905:4C6C3F849 01E6E1E17C5FE4A8DBCCCD3&&eun=gd3r&userid=89769&[log in to unmask]&mu _id=5089051> Smoking, hypertension, dyslipidemia, and type 2 diabetes each contribute to men's chance of developing significant peripheral artery disease and together account for most of the risk, a large prospective study showed. <http://broadcaster.medpagetoday.com/t?r=2&c=18331&l=368&ctl=6C905:4C6C3F849 01E6E1E17C5FE4A8DBCCCD3&&eun=gd3r&userid=89769&[log in to unmask]&mu _id=5089051> Full story <http://broadcaster.medpagetoday.com/t?r=2&c=18331&l=368&ctl=6C906:4C6C3F849 01E6E1E17C5FE4A8DBCCCD3&&eun=gd3r&userid=89769&[log in to unmask]&mu _id=5089051> Adherence to Warfarin Tx Not Long Term <http://broadcaster.medpagetoday.com/t?r=2&c=18331&l=368&ctl=6C906:4C6C3F849 01E6E1E17C5FE4A8DBCCCD3&&eun=gd3r&userid=89769&[log in to unmask]&mu _id=5089051> Older patients on warfarin therapy for atrial fibrillation are likely to stop treatment within 5 years, researchers reported. <http://broadcaster.medpagetoday.com/t?r=2&c=18331&l=368&ctl=6C906:4C6C3F849 01E6E1E17C5FE4A8DBCCCD3&&eun=gd3r&userid=89769&[log in to unmask]&mu _id=5089051> Full story Visit My.AmericanHeart.org <http://broadcaster.medpagetoday.com/t?r=2&c=18331&l=368&ctl=6C907:4C6C3F849 01E6E1E17C5FE4A8DBCCCD3&> for Professionals Visit MedPageToday.com <http://broadcaster.medpagetoday.com/t?r=2&c=18331&l=368&ctl=6C908:4C6C3F849 01E6E1E17C5FE4A8DBCCCD3&> for Breaking Medical News ADVERTISEMENT <http://ad.doubleclick.net/jump/medpagetoday/emails/cardiodaily/aha;prof=;sp ec=cardiology;pos=top;ugc=0;ct=nl;dcove=r;tile=2;sz=300x250;u=5089051;ord=10 244C6C3F84901E6E1E17C5FE4A8DBCCCD3?> Image removed by sender. Image removed by sender. CME Resources <http://broadcaster.medpagetoday.com/t?r=2&c=18331&l=368&ctl=6C909:4C6C3F849 01E6E1E17C5FE4A8DBCCCD3&> Reducing Cardiovascular Complications of Chronic Kidney Disease: New Prospectives in Improving Patient Outcomes Source: <http://broadcaster.medpagetoday.com/t?r=2&c=18331&l=368&ctl=6C909:4C6C3F849 01E6E1E17C5FE4A8DBCCCD3&> National Kidney Foundation <http://broadcaster.medpagetoday.com/t?r=2&c=18331&l=368&ctl=6C90A:4C6C3F849 01E6E1E17C5FE4A8DBCCCD3&> Build A Case in Type 2 Diabetes: Your Patients and GLP-1 Receptor Agonist Therapy Source: <http://broadcaster.medpagetoday.com/t?r=2&c=18331&l=368&ctl=6C90A:4C6C3F849 01E6E1E17C5FE4A8DBCCCD3&> The Institute for Medical and Nursing Education (IMNE) Image removed by sender. <http://ad.doubleclick.net/jump/medpagetoday/emails/cardiodaily/aha;prof=;sp ec=cardiology;pos=top;ugc=0;ct=nl;dcove=r;tile=16;sz=728x90;u=5089051;ord=10 244C6C3F84901E6E1E17C5FE4A8DBCCCD3?> Image removed by sender. Donate <http://broadcaster.medpagetoday.com/t?r=2&c=18331&l=368&ctl=6C90B:4C6C3F849 01E6E1E17C5FE4A8DBCCCD3&> | Forward this Message <http://broadcaster.medpagetoday.com/bin/ftaf?id=4C6C3F84901E6E1E17C5FE4A8DB CCCD3> Unsubscribe <http://www.medpagetoday.com/whatCountsUnsub/AHA/unSubScribe.cfm?unsub=aha&u [log in to unmask]> Manage your <http://broadcaster.medpagetoday.com/t?r=2&c=18331&l=368&ctl=6C90C:4C6C3F849 01E6E1E17C5FE4A8DBCCCD3&> Medpage Today Email Preferences AHA Privacy Policy <http://broadcaster.medpagetoday.com/t?r=2&c=18331&l=368&ctl=6C90D:4C6C3F849 01E6E1E17C5FE4A8DBCCCD3&> | MedPage Today Privacy Policy <http://broadcaster.medpagetoday.com/t?r=2&c=18331&l=368&ctl=6C90E:4C6C3F849 01E6E1E17C5FE4A8DBCCCD3&> | Ethics Policy <http://broadcaster.medpagetoday.com/t?r=2&c=18331&l=368&ctl=6C90F:4C6C3F849 01E6E1E17C5FE4A8DBCCCD3&> | Conflict of Interest Policy <http://broadcaster.medpagetoday.com/t?r=2&c=18331&l=368&ctl=6C910:4C6C3F849 01E6E1E17C5FE4A8DBCCCD3&> To unsubscribe via postal mail, please contact us at: American Heart Association Attn: Email Subscription Group 7272 Greenville Ave, Dallas, TX 75231 TECHNICAL QUESTIONS: [log in to unmask] MedPage Today, LLC. - Overlook at Great Notch - 150 Clove Road - Little Falls, New Jersey 07424 - Tel: (973) 890-0985 - Fax: (973) 890-1327 MedPage Today is the sponsor of the AHA\ASA Science News Cardiovascular Daily newsletter. Advertisers are not endorsed by AHA\ASA or MedPage Today. Image removed by sender. ----------------------- To change your mail settings or leave the C-PALSY list, go here: http://listserv.icors.org/SCRIPTS/WA-ICORS.EXE?SUBED1=c-palsy
